– Congruence has been awarded the Neuroscience Section Blitz Talk Award for transformative research in MC4R-related early-onset genetic obesity – – Congruence’s insights into the biology and pharmacology of MC4R deficiency and its proprietary drug discovery engine, Revenir™, identified…
